- Home
- /
- Treatment
- /
- Page 4
Treatments
The following database contains products that have been granted orphan status, or have been market approval in the EU or the USA.
You can filter the content by clicking on the titles: Product, Indication, Sponsor and Date. Clicking once, will filter the column alphabetically from A – Z and a second click on the same title will filter from Z – A.
Become a Partner.
Country | Product | Indication | Sponsor | Date |
---|---|---|---|---|
Arimoclomol | Inclusion Body Myositis | Orphazyme ApS;Ole Maaloes Vej 3, 2200 Copenhagen; | November 2, 2017 | |
Replication defective herpes simplex type 1 virus (HSV-1) vector expressing human COL7 protein | Dystrophic epidermolysis bullosa | Krystal Biotech, LLC;2100 Wharton Street, Suite 701;Pittsburgh, Pennsylvania, 15203 | November 2, 2017 | |
Baricitinib | Pediatric systemic lupus erythematosus | Eli Lilly and Company;Lilly Corporate Center;Indianapolis, Indiana, 46285 | November 2, 2017 | |
Live bacterial product consisting of defined consortia of Clostridium clusters live bacterial product consisting of defined consortia of Clostridium clusters | Prevention of recurrent Clostridium difficile infection in individuals with prior recurrent Clostridium difficile infection | Vedanta Biosciences, Inc.;19 Blackstone Street, Third Floor;Cambridge, Massachusetts, 02139 | November 2, 2017 | |
1-(fluoro-18F)-3-((2-((1E,3E)-4-(6-(methylamino)pyridin-3-yl)buta-1,3-dien-1-yl)benzo[d]thiazol-6-yl)oxy)propan-2-ol | Progressive supranuclear palsy | Aprinoia Therapeutics;17F, No. 3 Yuanqu Street;Nangang District | November 1, 2017 | |
Vigabatrin and cosyntropin | West syndrome | West Therapeutic Development, LLC;540 Ziegler Drive;Grayslake, Illinois, 60030 | November 1, 2017 | |
(+)-1-(3-(aminomethyl) phenyl)-N-(5-((3-cyanophenyl)(cyclopropylmethylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide dihydrochloride | C1-inhibitor-dependent angioedema (including prevention and treatment of attacks) | BioCryst Pharmaceuticals, Inc.;4505 Emperor Blvd, Suite 200200;Durham, North Carolina, 27703 | November 1, 2017 | |
Indoximod | Metastatic Melanoma | NewLink Genetics Corporation;2503 South Loop Drive, Suite 5100;Ames, Iowa, 50010 | October 26, 2017 | |
Copper sulfate | Keratoconus | iVeena Drug Delivery Systems, Inc.;391 Chipeta Way, Suite I;Salt Lake City, Utah, 84108 | October 26, 2017 | |
Seribantumab | Non-small cell lung cancer | Merrimack Pharmaceuticals, Inc.;1 Kendall Square, Suite B7201;Cambridge, Massachusetts, 02139 | October 25, 2017 | |
9-cis,12-cis-11,11-D2-linoleic acid ethyl ester | PLA2G6-associated neurodegeneration | Retrotope, Inc.;4300 El Camino Real, Suite 201;Los Altos, California, 94022 | October 24, 2017 | |
Glasdegib | Myelodysplastic syndrome | Pfizer, Inc.;445 Eastern Point Road;Groton, Connecticut, 06340 | October 20, 2017 | |
Glepaglutide | Short bowel syndrome | Zealand Pharma A/S;36 Smedeland;Glostrup | October 20, 2017 | |
Valbenazine | Tourette syndrome | Neurocrine Biosciences, Inc.;12780 El Camino Real;San Diego, California, 92130 | October 19, 2017 | |
A strain of modified live probiotic bacterium Escherichia coli (E.coli) Nissle 1917 that has been modified to treat phenylketonuria by consuming phenylalanine within the gastrointestinal tract | Phenylketonuria | Synlogic, Inc.;200 Sidney Street, Suite 320;Cambridge, Massachusetts, 02139 | October 18, 2017 | |
Vatiquinone | Pontocerebellar Hypoplasia | BioElectron Technology Corporation;350 North Bernardo Avenue;Mountain View, California, 94043 | October 18, 2017 | |
Glucopyranosyl lipid A | Follicular lymphoma | Immune Design Ltd | October 16, 2017 | |
Humanised monoclonal antibody targeting B-cell maturation antigen conjugated with maleimidocaproyl monomethyl auristatin F | Multiple myeloma | GlaxoSmithKline Trading Services Limited | October 16, 2017 | |
Ofranergene obadenovec | Ovarian cancer | Envigo Pharma Consulting Ltd | October 16, 2017 | |
Recombinant adeno-associated viral vector serotype 5 encodingStaphylococcus aureusCas9 endonuclease and two guide RNAs complementary to two regions of intron 26 of theCEP290gene | Leber congenital amaurosis | Pharma Gateway AB | October 16, 2017 | |
Autologous human peripheral blood mononuclear cells incubated ex vivo with protein TBX-4000 (Tat-MYC) | Malignant melanoma Stages IIb to IV | Taiga Biotechnologies, Inc.;12635 Montview Boulevard, Fitzsimmons BBioscience Park Center;Aurora, Colorado, 80045 | October 16, 2017 | |
Entospletinib | Acute myeloid leukaemia | Gilead Sciences International Ltd. | October 16, 2017 | |
Seladelpar | Primary biliary cirrhosis | Larode Ltd | October 16, 2017 | |
Glasdegib maleate | Acute myeloid leukaemia | Pfizer Limited | October 16, 2017 | |
Synthetic cyclic 8 amino acid analogue of human unacylated ghrelin | Prader-Willi syndrome | Alizé Pharma | October 16, 2017 |